|
CHESTERFIELD COUNTY, VA — Board of Supervisors Chair Mark Miller, Ph.D., (Midlothian District), has announced the formation of the Chair’s Plant Medicine Ad Hoc Committee, formed in response to growing interest in innovative approaches to mental health care—particularly for the veteran community. Dr. Miller announced the committee’s formation during Wednesday evening’s Board of Supervisors meeting.
“Post Traumatic Stress Disorder remains a significant challenge for many veterans in Virginia. While our state’s estimated PTSD prevalence of 5 percent is slightly below the national average, the impact on individuals and families is profound,” Dr. Miller said.
“Traditional treatments, including selective serotonin reuptake inhibitors (SSRIs) and cognitive behavioral therapy, have helped many, but they are not effective for everyone,” he added. “In recent years, a substantial body of research has emerged around plant medicine therapies, especially those involving psilocybin. Early clinical results show meaningful reductions in PTSD symptoms when these therapies are administered under strict medical supervision and regulatory oversight.”
The purpose of the committee is not to endorse any specific treatment, but to responsibly examine evidence, understand the regulatory landscape, and explore whether emerging therapies could play a role in improving outcomes for veterans and others in the community.
“My goal is to ensure that any future recommendations are grounded in science, guided by safety, and aligned with our responsibility to the public within state and federal laws,” Dr. Miller said.
The Chair’s Plant Medicine Ad Hoc Committee will include 18 individuals, collectively representing expertise and experience that will guide the committee’s work and evaluation of three main topics:
- How to best work with the Virginia Board of Pharmacy should plant medicines be decriminalized at the state and federal levels. Examples of current legislation at the state level include HB1347 and SB379, which direct the Board of Pharmacy to create regulations for psilocybin should it become legal at the federal level. Each has passed the House and Senate and will now go to the governor.
- What other state and local programs exist across the country and how they have implemented treatment programs, focusing on what has worked and not worked, and challenges encountered.
- What training is necessary for professionals to clinically assist those who are suffering from PTSD, depression, anxiety, etc.
Meetings of the Chair’s Plant Medicine Ad Hoc Committee will be open to the public and legally noticed ahead of time. The committee shall determine the manner in which to report out its activities and findings to the Board of Supervisors, but any such report issued would be by Nov. 30, 2026, and, if any public presentation, by the December 2026 Board of Supervisors meeting. The names of the committee members have been provided to the Clerk to the Board.
# # #
|